Allison Oswalt, PharmD picture of Allison Oswalt

Assistant Professor

Depart of Pharmacy Practice
Phone: (501) 526-5582
Fax: (501) 296-1168
Office: ED II 6/134B
Email: AOswalt@uams.edu


Education & Training

  • Post-Graduate Year Two Critical Care Pharmacy Residency, Virginia Commonwealth University Health System, Richmond, Virginia, 2017.
  • Post-Graduate Year One Pharmacy Practice Residency, Virginia Commonwealth University Health System, Richmond, Virginia, 2016.
  • Doctor of Pharmacy, University of Florida College of Pharmacy, Gainesville, Florida, 2015.
  • Bachelor of Science in Chemistry, University of Florida, Gainesville, Florida, 2010.

Teaching Responsibilities

  • PHPR 7304 Therapeutics III: Critical Care Module
    Management of Pain, Agitation, and Delirium; Management of Glucose Disorders; Acid-Base Disorders; Septic Shock; Pulmonary Hypertension

Clinical Practice

  • Clinical Pharmacist, Medical Intensive Care Unit, UAMS Medical Center, Little Rock, Arkansas

Research & Scholarly Interests

  • Sepsis Management; Infectious Disease; Vasopressors

Memberships

  • American College of Clinical Pharmacy
  • American Society of Health-System Pharmacists
  • Arkansas Association of Health-System Pharmacists
  • Kappa Epsilon Pharmaceutical Fraternity
  • Society of Critical Care Medicine

Publications

Oswalt A, Joseph AC, Sima A, Kurczewski L. Evaluation of Intravenous Vancomycin Pharmacokinetic Parameters in Patients With Acute Brain Injury. J Pharm Pract. 2017 Jan 1:897190017743133 [Epub ahead of print].

Oswalt A, Kurczewski L, Joseph AC, Sima A. Evaluation of Vancomycin Pharmacokinetic Parameters in Patients with Acute Brain Injury. Critical Care Medicine. 2016 Dec;44(12):268.

Cahoon WD Jr, Oswalt AK, Francis KE, Magee LC, Lowe DK. Cangrelor Bridge Therapy for Gastroduodenal Biopsy: A Case Report. J Pharm Pract. 2016 Mar 21.

Bruce E, Shenoy V, Rathinasabapathy A, Espejo A, Horowitz A, Oswalt A, Francis J, Nair A, Unger T, Raizada M, Stecklings U, Sumners C, Katovich M. Selective Activation of AT2 Receptor Attenuates Progression of Pulmonary Hypertension and Inhibits Cardiopulmonary Fibrosis. Br J Pharmacol. 2015 May;172(9):2219-31.


Curriculum Vitae